Comparison of Commercial ELISA Methods for the Measurement of Prothrombin Fragment 1 + 2 - Rebuttal

Thromb Haemost 1995; 73(03): 549-550
DOI: 10.1055/s-0038-1653814

Letters to the Editor

Schattauer GmbH Stuttgart

Authors

A Tripodi

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University, Milano, Italy
V Chantarangkul

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University, Milano, Italy
M Braga

¹The Epidemiology Laboratory IRCCS Maggiore Hospital, Milano, Italy
P M Mannucci

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University, Milano, Italy

>References
1 D’Angelo A, Della Valle P, Calori G, Galli L, Vigano D’Angelo S. Harmonization of commercial ELISA methods for the measurement of prothrombin fragment 1 + 2: is it feasible. Thromb Haemost 1995; 73: 548
2 Tripodi A, Chantarangkul V, Bottasso B, Mannucci PM. Poor comparability of prothrombin fragment 1 + 2 values measured by two commercial ELISA methods: Influence of different anticoagulants and standards. Thromb Haemost 1994; 71: 605-608
3 Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements. Thromb Res 1991; 63: 617-628
4 Leroy-Matheron C, Gouault-Heilmann M. Influence of conditions of blood sampling on coagulation makers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements. Thromb Res 1994; 74: 399-407
5 Hultin MB, Hoffman CJ, Groth ML. The prothrombin fragment F1.2 assay: comparison of anticoagulants for diagnosis of hypercoagulability in primary pulmonary hypertension and other disorders. Thromb Haemost 1993; 69: 625
6 Hursting MJ, Greenberg CS, Stead AG, Slaughter TF, Witt DJ. Correlation of plasma prothrombin fragment 1.2 (F1.2) measured by two commercial assays. Blood 1994; 84 Suppl (Suppl. 01) 199 a
7 Fleiss JL. Statistical methods for rates and proportions. Wiley; New York, N. Y: 1981. pp 212-225